Table 1.
Study sessions and procedure.
| Procedures | Intervention period | Observation period | ||||||||||||||||||||
|
|
V1a | H1b | H2 | V2 | H3 | V3 | H4 | V4 | H5 | V5 | ||||||||||||
| Informed consent | ✓ |
|
|
|
|
|
|
|
|
|
||||||||||||
| Inclusion and exclusion criteria | ✓ |
|
|
|
|
|
|
|
|
|
||||||||||||
| Physical examination | ✓ |
|
|
|
|
|
|
|
|
✓ | ||||||||||||
| Medical history | ✓ |
|
|
|
|
|
|
|
|
|
||||||||||||
| Demographics | ✓ |
|
|
|
|
|
|
|
|
|
||||||||||||
| Anthropometry | ✓ |
|
|
✓ |
|
✓ |
|
✓ |
|
✓ | ||||||||||||
| Randomization | ✓ |
|
|
|
|
|
|
|
|
|
||||||||||||
| Fecal samples |
|
✓ | ✓ |
|
✓ |
|
✓ |
|
✓ |
|
||||||||||||
| Questionnaires |
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
IGSQ-13c | ✓ |
|
|
✓ |
|
✓ |
|
|
|
|
|||||||||||
|
|
PISId |
|
|
|
✓ |
|
✓ |
|
✓ |
|
✓ | |||||||||||
|
|
BISQe | ✓ |
|
|
✓ |
|
✓ |
|
|
|
|
|||||||||||
|
|
ITQoL-SFf 47 |
|
|
|
✓ |
|
✓ |
|
|
|
|
|||||||||||
| Diaries |
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
Stooling | ✓ |
|
✓ |
|
✓ |
|
|
|
|
|
|||||||||||
|
|
3-day food |
|
|
|
|
✓ |
|
✓ |
|
✓ |
|
|||||||||||
|
|
Breastfeeding (BGg only) | ✓ |
|
|
✓ |
|
✓ |
|
✓ |
|
✓ | |||||||||||
|
|
Formula milk intake | ✓ |
|
|
✓ |
|
✓ |
|
✓ |
|
✓ | |||||||||||
|
|
Infant illness | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||||||
| Investigational product |
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
Administer trial formula (EGh/CGi only) |
|
✓ | ✓ | ✓ | ✓ | ✓ |
|
|
|
|
|||||||||||
|
|
Adverse event collection | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||||||
aV: visit.
bH: home.
cIGSQ: Infant Gastrointestinal Symptom Questionnaire.
dPISI: Pediatric Immune System Index.
eBISQ: Brief Infant Sleep Questionnaire.
fITQoL-SF: Infant Toddler Quality of Life Questionnaire-Short Form.
gBG: breastfed group.
hEG: experimental group.
iCG: control group.